Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Pretax margin (%)

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 20254.7+418.74%
Dec 31, 20240.9-129.65%
Dec 31, 2023-3.1-45.55%
Dec 31, 2022-5.6-69.63%
Dec 31, 2021-18.5+17.60%
Sep 30, 2021-15.7+43.41%
Sep 30, 2020-10.9-78.39%
Sep 30, 2019-50.6+600.52%
Sep 30, 2018-7.2-183.16%
Sep 30, 20178.7+2.20%
Sep 30, 20168.5-30.62%
Sep 30, 201512.3+95.06%
Sep 30, 20146.3-50.32%
Sep 30, 201312.7-38.36%
Sep 30, 201220.5-23.80%
Sep 30, 201126.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat